Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Peripheral Inflammation and Demyelinating Diseases.
Episomal Induced Pluripotent Stem Cells Promote Functional Recovery of Transected Murine Peripheral Nerve.
A New Strategy for Fast MRI-Based Quantification of the Myelin Water Fraction: Application to Brain Imaging in Infants.
Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis.
Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
Perturbed cholesterol homeostasis in aging spinal cord.
Neurogenic bowel dysfunction (NBD) translation and linguistic validation to classical Arabic.
Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury.
From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases.
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis.
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
[May neuroimaging findings of a child with multiple sclerosis surprise us? Clinical and radiological observation].
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Pages
« first
‹ previous
…
815
816
817
818
819
820
821
822
823
…
next ›
last »